Standard BioTools Inc.
At Close: 4:00 PM
LAB Stock Price Graph
LAB Stock Price Today
Standard BioTools Inc. (LAB) stock rallied over 0.41% intraday to trade at $2.45 a share on NASDAQ. The stock opened with a loss of -21.20% at $1.97 and touched an intraday high of $1.97, falling -2.00% against the last close of $2.50. The Standard BioTools Inc. in stock market went to a low of $1.81 during the session.
LAB Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
LAB Stock Price History Chart
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Frequently Asked Questions
What is the current Standard BioTools Inc. (LAB) stock price?
Standard BioTools Inc. (NASDAQ: LAB) stock price is $2.45 in the last trading session. During the trading session, LAB stock reached the peak price of $1.97 while $1.81 was the lowest point it dropped to. The percentage change in LAB stock occurred in the recent session was 0.41% while the dollar amount for the price change in LAB stock was $0.01.
LAB's industry and sector of operation?
The NASDAQ listed LAB is part of Diagnostics & Research industry that operates in the broader Healthcare sector. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide.
Who are the executives of LAB?
Senior Director of Corporation Communications
Senior Vice President, GM & Head of Strategic Marketing
Mr. Stephen Christopher Linthwaite
Mr. Peter DeNardo
How LAB did perform over past 52-week?
LAB's closing price is 0.65% higher than its 52-week low of $0.92 where as its distance from 52-week high of $3.16 is -0.51%.
How many employees does LAB have?
Number of LAB employees currently stands at N/A. LAB operates from 2 Tower Place, South San Francisco, CA 94080, US.
Link for LAB official website?
Official Website of LAB is: https://www.fluidigm.com
How do I contact LAB?
How many shares of LAB are traded daily?
LAB stock volume for the day was 294420.00 shares. The average number of LAB shares traded daily for last 3 months was 634.7 Thousands.
What is the market cap of LAB currently?
The market value of LAB currently stands at $194.51 Million with its latest stock price at $2.45 and N/A of its shares outstanding.